15 Days Price Change
Closing In
WEBSITE Inc. Year: 2015 Industry: Hospital & Healthcare Services Listed Page
Buy unlisted shares early and participate in the growth before public listing.
Company Promoters
Pre Issue Share Holding 99.98%
Post Issue Share Holding 71.29%
Listing Price: 83
Listing Gain: 4.82%
Current Price: 76.5
Gain On Issue: 76.5 | 0%
GMP: --
GMP %: -- %
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 189 | 14,931 |
| Retail (Max) | 13 | 2457 | 194,103 |
| S-HNI (Min) | 14 | 2646 | 209,034 |
| S-HNI (Max) | 66 | 12474 | 985,446 |
| B-HNI (Min) | 67 | 12663 | 1,000,377 |
1) Funding capital expenditure towards establishment of New IVF Centers of our Company.2) Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company.3) General Corporate Purposes.
| Category | Nos | Bid | Bid (x) |
|---|---|---|---|
| QIB | 4177240 | 6785478 | 1.6x |
| NII | 3132930 | 44022069 | 14.1x |
| Retail | 7310170 | 55542942 | 7.6x |
| EMP | 0 | 0 | 0x |
| Total | 14620340 | 106350489 | 7.3x |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|
| Net Sales | 37 | 44 | 48 | 71 | |
| Other Income | 0 | 0 | 0 | 0 | |
| Total Income | 37 | 44 | 48 | 71 | |
| Total Expenditure | 23 | 24 | 28 | 42 | |
| Operating Profit | 14 | 20 | 20 | 29 | |
| Interest | 1 | 0 | 1 | 2 | |
| Depreciation | 1 | 1 | 2 | 2 | |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
| Profit Before Tax | 12 | 18 | 17 | 25 | |
| Provision for Tax | 3 | 5 | 6 | 6 | |
| Profit After Tax | 9 | 14 | 10 | 19 | |
| Adjustments | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | 9 | 14 | 10 | 19 | |
| Adjusted Earnings Per Share | 1.4 | 2.2 | 1.7 | 3.1 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Shareholder's Funds | 9 | 23 | 27 | 46 |
| Minority's Interest | 0 | 0 | 0 | 0 |
| Borrowings | 2 | 2 | 2 | 2 |
| Other Non-Current Liabilities | 0 | 2 | 2 | 2 |
| Total Current Liabilities | 6 | 10 | 20 | 38 |
| Total Liabilities | 18 | 37 | 51 | 89 |
| Fixed Assets | 4 | 18 | 19 | 18 |
| Other Non-Current Assets | 0 | 0 | 3 | 17 |
| Total Current Assets | 14 | 18 | 30 | 54 |
| Total Assets | 18 | 37 | 51 | 89 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 2 | 15 | 12 |
| Cash Flow from Operating Activities | -1 | 24 | 3 | 9 |
| Cash Flow from Investing Activities | -1 | -16 | -5 | -15 |
| Cash Flow from Financing Activities | 3 | 5 | -1 | 2 |
| Net Cash Inflow / Outflow | 0 | 13 | -3 | -5 |
| Closing Cash & Cash Equivalent | 2 | 15 | 12 | 7 |
| # | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | 1.44 | 2.2 | 1.68 | 3.12 |
| CEPS(Rs) | 1.6 | 2.44 | 2.03 | 3.45 |
| DPS(Rs) | 0 | 1.03 | 0 | 0 |
| Book NAV/Share(Rs) | 1.51 | 3.7 | 4.4 | 7.54 |
| Core EBITDA Margin(%) | 37.04 | 45.69 | 40.59 | 40.83 |
| EBIT Margin(%) | 34.39 | 42.5 | 36.63 | 38.27 |
| Pre Tax Margin(%) | 32.86 | 41.4 | 34.73 | 35.95 |
| PAT Margin (%) | 24.17 | 30.57 | 21.54 | 27.05 |
| Cash Profit Margin (%) | 26.83 | 33.82 | 26.05 | 29.94 |
| ROA(%) | 50.27 | 49.92 | 23.55 | 27.42 |
| ROE(%) | 94.99 | 84.47 | 41.5 | 52.2 |
| ROCE(%) | 82.39 | 78.74 | 46.65 | 50.15 |
| Receivable days | 64.91 | 30.54 | 55.26 | 119.89 |
| Inventory Days | 3.35 | 7.57 | 13.73 | 24.08 |
| Payable days | 114.13 | 87.5 | 72.31 | 178.13 |
| PER(x) | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 0 | 0 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.15 | -0.1 | 0.1 | 0.6 |
| EV/Core EBITDA(x) | 0.4 | -0.21 | 0.25 | 1.46 |
| Net Sales Growth(%) | 0 | 21.13 | 8.26 | 47.68 |
| EBIT Growth(%) | 0 | 49.7 | -6.68 | 54.28 |
| PAT Growth(%) | 0 | 53.21 | -23.72 | 85.4 |
| EPS Growth(%) | 0 | 53.21 | -23.72 | 85.39 |
| Debt/Equity(x) | 0.64 | 0.43 | 0.58 | 0.41 |
| Current Ratio(x) | 2.29 | 1.92 | 1.5 | 1.42 |
| Quick Ratio(x) | 2.23 | 1.76 | 1.39 | 1.23 |
| Interest Cover(x) | 22.44 | 38.53 | 19.23 | 16.46 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 48% | 24% | 0% | 0% |
| Operating Profit CAGR | 45% | 27% | 0% | 0% |
| PAT CAGR | 90% | 28% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 52% | 59% | 68% | 68% |
| ROCE Average | 50% | 59% | 64% | 64% |
Gaudium IVF and Women Health Ltd.
Naveen Kumar
011- 4885 8585
compliance@gaudiumivfcentre.com
B1/51, Janakpuri B-1
Gaudium IVF and Women Health Ltd.
Sarthi Capital Advisors Pvt Ltd.
Gaudium IVF and Women Health Ltd.
Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,ext to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400093 (old address - Bharat Tin Works building, 1st floor, Opp. Vasant Oasis, Andheri East Mumbai - 400 059 Tel: + 91 21 626 38200 Fax:
91-022-62638200
91-022-62638299
| #(Fig in Cr.) | Dec 2024 | Dec 2025 |
|---|---|---|
| Net Sales | 14 | 25 |
| Other Income | 0 | 0 |
| Total Income | 14 | 25 |
| Total Expenditure | 9 | 18 |
| Operating Profit | 6 | 7 |
| Interest | 0 | 1 |
| Depreciation | 1 | 0 |
| Exceptional Income / Expenses | 0 | 0 |
| Profit Before Tax | 5 | 5 |
| Provision for Tax | 1 | 1 |
| Profit After Tax | 3 | 4 |
| Adjustments | 0 | 0 |
| Profit After Adjustments | 3 | 4 |
| Adjusted Earnings Per Share | 0.6 | 0.6 |
When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.
For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.
Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.
Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.
Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.